Pleural plaques and the risk of pleural mesothelioma

Journal of the National Cancer Institute

Volumn 105, Issue 4, 2013, Pages 293-301

  Pairon, Jean Claude ^a,b,c   Laurent, François ^d,f   Rinaldo, Mickaël ^e,f   Clin, Bénédicte ^g,h,j   Andujar, Pascal ^a,b,c   Ameille, Jacques ^k   Brochard, Patrick ^e,f   Chammings, Soizick ^l   Ferretti, Gilbert ^e,m,n   Galateau Sallé, Françoise ^g,i,j   Gislard, Antoine ^o   Letourneux, Marc ^h,j   Luc, Amandine ^p,r   Schorlé, Evelyne ^s   Paris, Christophe ^p,q,r  

^a INSERM U955   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^e INSERM   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g Axe 2: 'Biology and Innovative Therapeutics for Locally Aggressive Cancers'   (France)

^h CAEN UNIVERSITY HOSPITAL   (France)

ⁱ MESOPATH National Reference Center   (France)

^j Mission Aupres Bernard Kouchner   (France)

^k RAYMOND POINCARÉ HOSPITAL   (France)

^l Institut Interuniversitaire de Medecine du Travail de Paris Ile de France   (France)

^m UNIV GRENOBLE ALPES   (France)

ⁿ GRENOBLE UNIVERSITY HOSPITAL   (France)

^o ROUEN UNIVERSITY HOSPITAL   (France)

^p UNIVERSITÉ DE LORRAINE   (France)

^q UNIVERSITÉ DE LORRAINE   (France)

^r UNIVERSITY HOSPITAL OF NANCY   (France)

^s ERSM Rhone Alpes   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FOLLOW UP; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL CARE; OCCUPATIONAL EXPOSURE; PLEURA MESOTHELIOMA; PLEURA PLAQUE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ASBESTOS; FRANCE; HUMANS; INCIDENCE; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; PLEURA; PLEURAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84875011842     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs513     Document Type: Article

References (36)

1. Goldberg M, Banaei A, Goldberg S, et al. Past occupational exposure to asbestos among men in France. Scand J Work Environ Health. 2000;26(1): 52-61.
2. Becklake MR, Bagatin E, Neder JA. Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int J Tuberc Lung Dis. 2007;11(4): 356-369.
3. Jamrozik E, de Klerk N, Musk AW. Asbestos-related disease. Intern Med J. 2011;41(5): 372-380.
4. Anonymous. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170(6): 691-715.
5. Berman DW, Crump KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(Suppl 1): 1-47.
6. Banks DE, Shi R, McLarty J, et al. American College of Chest Physicians consensus statement on the respiratory health effects of asbestos. Results of a Delphi study. Chest. 2009;135(6): 1619-1627.
7. Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health. 1997;23(2): 93-103.
8. Hillerdal G. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest. 1994;105(1): 144-150.
9. Karjalainen A, Pukkala E, Kauppinen T, Partanen T. Incidence of cancer among Finnish patients with asbestos-related pulmonary or pleural fibrosis. Cancer Causes Control. 1999;10(1): 51-57.
10. Reid A, de Klerk N, Ambrosini G, et al. The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. Occup Environ Med. 2005;62(10): 665-669.
11. Ameille J, Brochard P, Letourneux M, Paris C, Pairon J-C. Asbestosrelated cancer risk in patients with asbestosis or pleural plaques. Rev Mal Respir. 2011;28(6):e11-e17.
12. Paris C, Thierry S, Brochard P, et al. Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data. Eur Respir J. 2009;34(1): 72-79.
13. Ameille J, Letourneux M, Paris C, et al. Does asbestos exposure cause airway obstruction, in the absence of confirmed asbestosis? Am J Respir Crit Care Med. 2010;182(4): 526-530.
14. Clin B, Paris C, Ameille J, et al. Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis? Thorax. 2011;66(11): 985-991.
15. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3): 697-722.
16. Beigelman-Aubry C, Ferretti G, Mompoint D, et al. [Computed tomographic atlas of benign asbestos related pathology]. J Radiol. 2007;88(6): 845-862.
17. International Labour Office (ILO). Guidelines for the Use of the ILO International Classification of Radiographs of Pneumoconioses, Revised Edition 2000. Occupational Safety and Health Series, no. 22 (Rev 2000). Geneva, Switzerland: International Labour Office; 2002.
18. Jarad NA, Wilkinson P, Pearson MC, Rudd RM. A new high resolution computed tomography scoring system for pulmonary fibrosis, pleural disease, and emphysema in patients with asbestos related disease. Br J Ind Med. 1992;49(2): 73-84.
19. Goldberg M, Imbernon E, Rolland P, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med. 2006;63(6): 390-395.
20. Sandén A, Järvholm B. A study of possible predictors of mesothelioma in shipyard workers exposed to asbestos. J Occup Med. 1991;33(7): 770-773.
21. Koskinen K, Pukkala E, Martikainen R, Reijula K, Karjalainen A. Different measures of asbestos exposure in estimating risk of lung cancer and mesothelioma among construction workers. J Occup Environ Med. 2002;44(12): 1190-1196.
22. Aberle DR, Balmes Jr. Computed tomography of asbestos-related pulmonary parenchymal and pleural diseases. Clin Chest Med. 1991;12(1): 115-131.
23. Bianchi C, Brollo A, Ramani L, Zuch C. Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study. Am J Ind Med. 1997;32(5): 445-449.
24. Gemba K, Fujimoto N, Kato K, et al. National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci. 2012;103(3): 483-490.
25. Klebe S, Brownlee NA, Mahar A, et al. Sarcomatoid mesothelioma: a clinical- pathologic correlation of 326 cases. Mod Pathol. 2010;23(3): 470-479.
26. Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT. Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol. 2002;26(2): 55-65.
27. Karjalainen A, Karhunen PJ, Lalu K, et al. Pleural plaques and exposure to mineral fibres in a male urban necropsy population. Occup Environ Med. 1994;51(7): 456-460.
28. Broaddus VC, Everitt JI, Black B, Kane AB. Non-neoplastic and neoplastic pleural endpoints following fiber exposure. J Toxicol Environ Health B Crit Rev. 2011;14(1-4): 153-178.
29. Boutin C, Dumortier P, Rey F, Viallat JR, De Vuyst P. Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study. Am J Respir Crit Care Med. 1996;153(1): 444-449.
30. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 2010;7: 5.
31. Mitchev K, Dumortier P, De Vuyst P. "Black spots" and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol. 2002;26(9): 1198-1206.
32. Das M, Mühlenbruch G, Mahnken AH, et al. Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector- row CT. Eur Radiol. 2007;17(5): 1193-1199.
33. Mastrangelo G, Ballarin MN, Bellini E, et al. Feasibility of a screening programme for lung cancer in former asbestos workers. Occup Med (Lond). 2008;58(3): 175-180.
34. Tiitola M, Kivisaari L, Huuskonen MS, et al. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer. 2002;35(1): 17-22.
35. Roberts HC, Patsios DA, Paul NS, et al. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure. J Thorac Oncol. 2009;4(5): 620-628.
36. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5): 395-409.